Editorial: Complement and Immunotherapeutics

Front Immunol. 2021 Feb 24:12:663459. doi: 10.3389/fimmu.2021.663459. eCollection 2021.

Authors

Marcin Okrój¹, Elena Volokhina^{2

3}

Affiliations

¹ Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland.
² Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands.
³ Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.

No abstract available

Keywords: antibodies; complement; eculizumab; factor H; immunotherapy; rituximab.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Complement Activation / drug effects
Complement Activation / immunology
Complement System Proteins / drug effects
Complement System Proteins / immunology*
Complement System Proteins / metabolism
Drug Development* / methods
Humans
Immunomodulation / drug effects
Molecular Targeted Therapy*

Substances

Complement System Proteins